Envestnet Portfolio Solutions’s United Therapeutics UTHR Stock Holding History

Envestnet Portfolio Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87M	Buy	3,445 +60	+2%	+$33.8K	0.01%	511
2026 Q1	$2.01M	Sell	3,385 -212	-6%	-$106K	0.01%	456
2025 Q4	$1.75M	Buy	3,597 +47	+1%	+$21.9K	0.01%	579
2025 Q3	$1.49M	Sell	3,550 -104	-3%	-$35K	0.01%	608
2025 Q2	$1.05M	Buy	3,654 +2,660	+268%	+$795K	﹤0.01%	775
2025 Q1	$306K	Sell	994 -88	-8%	-$30.2K	﹤0.01%	1283
2024 Q4	$382K	Buy	1,082 +81	+8%	+$29.8K	﹤0.01%	1368
2024 Q3	$359K	Buy	1,001 +41	+4%	+$13.8K	﹤0.01%	1355
2024 Q2	$306K	Buy	+960	New	+$254K	﹤0.01%	1369

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Envestnet Portfolio Solutions's UTHR Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its United Therapeutics (UTHR) stake by 1.8% in Q2 2026, buying an estimated $33.8K and bringing the position to 3,445 shares worth $1.87M. The position accounts for 0.01% of the portfolio, ranked #511.

Envestnet Portfolio Solutions first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.01M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Envestnet Portfolio Solutions held 3,445 shares of United Therapeutics worth $1.87M as of Q2 2026.
Envestnet Portfolio Solutions bought 60 United Therapeutics shares in Q2 2026, an estimated $33.8K.
United Therapeutics made up 0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #511 holding.
Envestnet Portfolio Solutions first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
Envestnet Portfolio Solutions's United Therapeutics position peaked at $2.01M in Q1 2026.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.